Exosomes and Circulating Biomarkers Summit 2013

SELECTBIO Inaugural Exosomes and Circulating Biomarkers 2013 Summit Focuses on Cutting-Edge Science and Presentations from Academic and Industrial Researchers.

This meeting brings together the basic biology of exosomes coupled with their emerging potential utility as carriers of cellular cargo representing a treasure trove of biomarkers for the development of diagnostics in the future.

This conference will include presentations as well as panel discussions facilitating exchange of unpublished information. In addition to the science, data on the business opportunities of exosomes will be presented. Networking opportunities  abound with delegates from other conference tracks co-located with this event.

Finally, this conference brings together other classes of circulating biomarkers in an effort to provide an en bloc view of the current state of this field.

Keynote Speakers

Charles Cantor
Charles Cantor
Chief Scientific Officer, Sequenom
Bertrand Jordan
Bertrand Jordan
Emeritus Research Director, CNRS
Mostafa Ronaghi
Mostafa Ronaghi
Senior Vice President & Chief Technology Officer, Illumina Inc
Johan Skog
Johan Skog
Chief Scientific Officer, Exosome Diagnostics

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 31 August 2013

Agenda Topics

  • Classes of Circulating Biomarkers
    • Epigenetic Biomarkers
    • microRNA Biomarkers
    • mRNA Biomarkers
    • Protein Biomarkers
  • Emerging Themes in Research on Exosomes and Circulating Biomarkers
  • Exosome Biology
  • Exosomes as Sources of Circulating Biomarkers
  • Technologies for Capturing/Interrogating Circulating Biomarkers
  • Unmet Needs and Commercial Opportunities for Circulating Biomarkers

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
+1 510-857-4865

(find out more…)


Hsian-Rong Tseng, Professor, UCLA Geffen School of Medicine
Sunil Pandit, Senior Staff Biochemist, Siemens Healthcare Diagnostics
Dean Troyer, CEO, Provia Biologics
Christopher Cheng, Post Doctoral Researcher, Yale University
Leonora Balaj, Research Fellow, Mass General Hospital, Harvard Medical School
Iman Jilani, Associate Director, Pfizer
Dominique de Kleijn, Professor, National University of Singapore
Premal Shah, Director, Business Development, Genomic Health, Inc.
Robert Proulx, President, Silicon Biosystems
Karri Bradley, Partner, Klarquist Sparkmann, LLP
Gregory Scott, Patent Attorney, Klarquist Sparkman, LLP

Leave a Reply

Your email address will not be published. Required fields are marked *